Who
Kevin Patrick Danahy
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Pulse Biosciences.
In numbers
- Trades disclosed
- 66
- Buys
- 2
- Sells
- 10
- Bought
- $50K
- Sold
- $6.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Feb 2022
- Last trade
- 18 Feb 2026
- Last filed
- 23 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $7,6505,000 at $1.53 | filing |
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $118K5,000 at $23.64 | filing |
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $7,6505,000 at $1.53 | filing |
| 18 Feb 2026filed 23 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $118K5,000 at $23.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $31K20,000 at $1.53 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $473K20,000 at $23.63 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $31K20,000 at $1.53 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $473K20,000 at $23.63 | filing |
| 17 Feb 2026filed 17 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $31K20,000 at $1.53 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $471K20,000 at $23.53 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $31K20,000 at $1.53 | filing |
| 13 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $471K20,000 at $23.53 | filing |
| 12 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $31K20,000 at $1.53 | filing |
| 12 Feb 2026filed 17 Feb 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $467K20,000 at $23.37 | filing |
News
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule TreatmentPLSE · rttnews.com · 14 Oct 2026
0 headlines in the last 90 days name Kevin Patrick Danahy; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.